Abstract
There is great interest from pharmaceutical companies in finding an appropriate treatment for patients with cancer which presented resistance to drugs commonly used to fight the cancer. Therefore, it is necessary to search for new genetic markers that are associated with the patient's predisposition to react differently than expected to the drug effect. For this purpose, several studies h…